Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway
Cell Biology and Toxicology · 2025
DOI: 10.1007/s10565-024-09975-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2025. Verfasst von Xiaoming Ji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurobiology, Hebei Medical University, Shijiazhuang, 050017, China. Hauptthemen laut MEDLINE: Ketamine, Neuralgia, Methyltransferases, Depression. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Esketamine, a newly developed antidepressant, is the subject of this research which seeks to explore its impact on depressive symptoms in neuropathic pain mice and the potential molecular mechanisms involved. Through transcriptome sequencing and bioinformatics analysis combined with in vivo studies, it was identified that esketamine markedly boosts the levels of the m6A methyltransferase METTL3 and the AMPA receptor GluA1 subunit. Esketamine activates METTL3, allowing it to bind with GluA1 mRNA, promoting m6A modification, thereby enhancing GluA1 expression at synapses. Through this mechanism, esketamine may reduce depressive-like behavior in neuropathic pain mice, providing new insights into the potential applications of esketamine and novel therapeutic avenues for neuropathic pain and depressive behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurobiology, Hebei Medical University, Shijiazhuang, 050017, China.
- Neuroscience Research Center, Hebei Medical University, Shijiazhuang, 050017, China.
- Department of Stomatology, Peoples Hospital, Shizhu Tujia Autonomous County, Chongqing, 409100, China.
- Core Facilities and Centers, Hebei Medical University, Shijiazhuang, 050017, China.
- Changan Dental Clinic, Xinqidian Dental Medical Services Co., Ltd, Shijiazhuang, 050000, China.
- Department of Neurology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Zitieren
APA
Ji, X., Huang, Z., Zhou, C., Wang, Y., Geng, D., Zhang, G., Kang, Y., Cui, R., Wang, J., & Zhang, T. (2025). Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-024-09975-1
Vancouver
Ji X, Huang Z, Zhou C, Wang Y, Geng D, Zhang G, et al. Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway. Cell Biology and Toxicology. 2025. doi:10.1007/s10565-024-09975-1
BibTeX
@article{Ji2025,
author = {Ji, Xiaoming and Huang, Zhimin and Zhou, Chenming and Wang, Yu and Geng, Dongliang and Zhang, Guoliang and Kang, Yunxiao and Cui, Rui and Wang, Jinyang and Zhang, Tianyun},
title = {Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway},
journal = {Cell Biology and Toxicology},
year = {2025},
doi = {10.1007/s10565-024-09975-1}
}
EUVIMED